A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Degeneration

NCT00139282 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Conditions

"Wet" Age-Related Macular Degeneration

Interventions

DRUG: Squalamine Lactate

Sponsor

Genaera Corporation